Jessica Zhou

Partner, Hong Kong SAR



Jessica Zhou is a partner in White & Case's Capital Markets practice based in Hong Kong. She specializes in the representation of issuers and underwriters in connection with Rule 144A/Regulation S, Regulation S only and SEC-registered debt and equity offerings. She also has significant experience in international financing transactions, including high-yield bond offerings, acquisition finance, transportation and satellite finance, pre-IPO investments and financial restructurings.

Prior to joining White & Case, Jessica worked at the New York and Hong Kong offices of another leading international law firm. Her experience also includes a secondment at a major international investment bank, where she advised on capital markets and merger & acquisition transactions in the Asia Pacific region.

Bars and Courts
Solicitor of the High Court of Hong Kong
New York State Bar
Columbia University
University of California, Irvine
Beijing Foreign Studies University


Jessica's recent representative experience includes:

Advised Deutsche Bank, as sole global coordinator and left lead bookrunner, Bank of America Merrill Lynch as joint bookrunner and ANZ and BOC International as joint bookrunners (passive) in the Rule 144A/Regulation S offering of senior secured notes by Studio City Company Limited (SCC). The offering consisted of US$350 million aggregate principal amount 5.875% senior secured notes due 2019, and US$850 million aggregate principal amount 7.25% senior secured notes due 2021. This deal won "High Yield Deal of the Year" Award at the IFLR Asia Awards 2017.

Advised Initial purchasers, in connection with MGM China Holdings Limited"s debut 144A/Regulation S debt issuance of senior notes in an aggregate amount of US$1.5 billion, comprising two tranches, a five-year tranche of US$750 million 5.375% senior notes due 2024 and a seven-year tranche of US$750 million 5.875% senior notes due 2026. The deal won the "Best Corporate Bond Deal of the Year" by The Asset Country Awards 2019.

Advised PAG as an investor in the private placement of US$200 million 6.00% secured convertible bonds due 2019 by Top Spring International Holdings Limited, a Hong Kong-listed PRC real estate developer. The deal involved two tranches of notes, with the first tranche closing on 6 January 2016 and the second tranche on 21 March 2016. PAG participated in both tranches. This deal won China Business Law Journal Convertible Bonds Deal of the Year 2016.

Advised China Molybdenum Co., Ltd. on its issuance of unrated US$300 million 5.48% guaranteed bonds due 2022. China Molybdenum is a leading global diversified mining conglomerate principally engaged in the mining and processing, smelting and deep processing of non-ferrous metals and/or minerals including copper, cobalt, molybdenum, tungsten, niobium and phosphate. 

Advised Greentown China Holdings Limited, a Chinese luxury real estate developer listed on the Hong Kong Stock Exchange, in its 364-day Regulation S high yield notes offering of US$600 million 4.55% Senior Notes due 2020.

Advised CDBI Treasure I Limited, as issuer, China Development Bank International Holdings Limited, as guarantor, and China Development Bank Capital Corporation Limited, as keepwell and EIPU provider, in the establishment of a US$500 million medium term note programme, and in the subsequent Regultion S offering of US$500 million 2.25% Guaranteed Notes due 2021 under the programme. BOC International, Barclays, UBS and BOCOM HK Branch were arrangers.

Advised China Water Affairs in its Regulation S offering of US$300 million 5.25% Senior Notes due 2022. Morgan Stanley acted as the sole global coordinator and bookrunner. China Water Affairs is one of the largest publicly-listed water supply companies in China based on volume of water sold. This was its debut bond offering in the international capital market.

Advised Deutsche Bank AG, Singapore Branch as sole global coordinator and left lead bookrunner, and joint bookrunners, in the Rule 144A/Regulation S offering of US$1 billion 5.125% senior notes due 2029 of Wynn Macau, Limited.

Advised Deutsche Bank AG, Singapore Branch as sole global coordinator and left lead bookrunner, Morgan Stanley & Co. LLC, Australia and New Zealand Banking Group Limited as joint bookrunner, and other initial purchasers in the Rule 144A/Regulation S offering of US$900 million 5.375% senior notes due 2029 of Melco Resorts Finance Limited.

Advised joint lead managers in connection with LMIRT Capital Pte. Ltd.'s Regulation S offering of US$250 million 7.25% Senior Guaranteed Notes due 2024. LMIRT Capital Pte. Ltd. is a subsidiary of Lippo Malls Indonesia Retail Trust ("LMIRT"). The Notes are guaranteed by Perpetual (Asia) Limited, as the trustee of LMIRT. LMIRT is a premier retail real estate investment trust ("REIT") in Asia and the first and only Indonesian retail REIT listed on the Singapore Exchange Securities Trading Limited. It is shortlisted High Yield Deal of the Year by IFLR Asia-Pacific Awards 2020.

Jubilant Pharma Limited, a global integrated pharmaceutical company, in connection with its Regulation S offering of US$200 million 6.00% Senior Notes due 2024. Jubilant Pharma Limited is a wholly owned subsidiary of Jubilant Life Sciences Limited, a global integrated pharmaceutical and life sciences group listed on the BSE Limited and the National Stock Exchange of India Limited in India.

Advised Deutsche Bank, UBS and Morgan Stanley as underwriters in the US registered secondary sell-down by a subsidiary of Crown Resorts Limited (Crown) of shares in Melco Resorts & Entertainment Limited (MREL). The transaction consisted of an underwritten offering of MREL shares owned by Crown and a borrowing by the underwriters' affiliates of American depositary shares (ADSs) from Melco Leisure and Entertainment Group, another significant shareholder of MREL, which were resold in the same underwritten public offering to hedge the dealers' exposure under cash-settled swap transactions with Crown. MREL is a developer, owner and operator of casino gaming and entertainment casino resort facilities in Asia, and its shares are listed on NASDAQ.